Novocure
NVCR
#4715
Rank
$1.29 B
Marketcap
Jersey
Country
$12.09
Share price
0.33%
Change (1 day)
-81.02%
Change (1 year)
Categories
Operating Margin for Novocure (NVCR)
Operating Margin as of April 2024 (TTM): -37.52%
According to Novocure 's latest financial reports and stock price the company's current Operating Margin is -37.52%. At the end of 2022 the company had an Operating Margin of -15.22%.
Operating Margin history for Novocure from 2015 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -15.22% | 56.35% |
| 2021 | -9.73% | -365.81% |
| 2020 | 3.66% | -245.79% |
| 2019 | -2.51% | -86.44% |
| 2018 | -18.52% | -32.4% |
| 2017 | -27.40% | -81.31% |
| 2016 | -146.54% | -54.75% |
| 2015 | -323.83% | -37.53% |
| 2014 | -518.40% | -30.27% |
| 2013 | -743.48% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | -591.52% | 1,476.55% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | -129.00% | 243.82% | 🇬🇧 UK |
 Novavax NVAX | -149.57% | 298.64% | 🇺🇸 USA |
 Novocure
NVCR | -37.52% | 0.00% | Jersey |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.